ALIM is not traded on ASX so ALIM is not able to do a press release on the ASX. PSDV is traded on the ASX and will do a press release of the FDA decision since it will cause significant price movement. So PSDV should do a press release on the ASX security, you are so naive.
You are so naïve.
ALIM owns the NDA, not PSDV. In fact, PSDV should not issue all press related to this drug since it only provides the delivery technology.
I do believe that this will recover if it does gap down tomorrow. This isn't a make or break moment for this company, but it's still going to lose me money that i will have to regain. And that's never a position i like to be in.
There is no crying in the stock market!!! Seriously tho, ALIM already has sales for this product in Europe, and it's been recommended for approval/reimbursement in the UK, approval there likely soon. If no FDA approval tomorrow, it could dip hard for a minute, but it won't last. Hold tight. JMHO.
2.5? I don't believe that lol. The way i look at it best case scenario for FDA not approving would be a least down to around $2. But probably further than that i don't know.
Sigh I'm gonna go find a corner to cry in.